Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Ted Butler: Silver’s Moment is Here, Time for... July 15, 2025 Top 10 Uranium-producing Countries June 3, 2025 Teck Greenlights Highland Valley Expansion After Beating Q2... July 26, 2025 Germany, Italy Face Pressure to Repatriate US$245 Billion... June 25, 2025 Silver Crown Royalties Closes Final Tranche of its... July 14, 2025 Resignation of Managing Director/CEO July 21, 2025 Agreement to Acquire Major Drill-Ready Antimony-Gold-Tungsten Project in... June 11, 2025 First Assay Results from Rae Copper Project Returns... April 30, 2025 Buffett Hands Over Reins, What’s Next for Berkshire’s... May 10, 2025 Completion of Tranche 1 Equity Placement & Cleansing... July 10, 2025
